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Objective: Aneurysms-osteoarthritis syndrome (AOS), caused by SMAD3 mutations, is a recently described autosomal-
dominant syndrome characterized by arterial aneurysms, tortuosity, and aortic dissections in combination with osteoar-
thritis. Our objective was to evaluate the AOS-related vascular consequences in the visceral and iliac arteries and raise
awareness for this aggressive syndrome among vascular specialists.
Methods:AllAOSpatientsweremonitored regularly according to our clinical AOSprotocol. The study included thosewith one
or more visceral aneurysms or tortuosity, or both. Clinical and surgical data were obtained from record abstraction.
Results: The study included 17 AOS patients (47% men) aged 47  13 years. A total of 73 aneurysms were encountered,
of which 46 were located in the abdomen. The common iliac artery was most commonly affected (37%), followed by the
superior mesenteric artery (15%), celiac trunk (11%), and splenic artery (9%). Rapid aneurysm growth<1 year was found
in three arteries (gastric, hepatic, and vertebral artery). Furthermore, arterial tortuosity was noted in 94% of patients.
Four patients underwent six elective (endo) vascular interventions for aneurysms in the iliac, hepatic, gastric, or splenic
artery, without major perioperative or postoperative complications.
Conclusions: AOS predisposes patients to widespread visceral and iliac artery aneurysms and extreme arterial
tortuosity. Early elective aneurysm repair should be considered because the risk of aneurysm rupture is estimated to
be very high and elective (endo) vascular interventions were not complicated by fragility of arterial tissue. Given the
aggressive behavior of AOS, it is of utmost importance that vascular specialists are aware of this new syndrome.
( J Vasc Surg 2013;57:96-102.)
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aVisceral and iliac aneurysms are relatively rare, yet po-
tentially catastrophic when rupturing.1-4 Although most
visceral and iliac aneurysms are degenerative, they can also
be encountered in the setting of connective tissue disor-
ders, such as Loeys-Dietz and vascular type Ehlers-Danlos
syndrome.5-7 Recently, our group discovered a new syn-
drome: the aneurysms-osteoarthritis syndrome (AOS).8
This autosomal-dominant connective tissue disorder is caused
by heterozygous mutations in the SMAD3 gene, located on
chromosome 15q22.33 (OMIM#613795).8 The syndrome
is typically characterized by widespread arterial aneurysms
and tortuosity, early-onset joint abnormalities, and mild
craniofacial and cutaneous features.8-11 Penetrance is
nearly 100%, and so far, AOS has only been identified in
families originating from North America and Europe.10,12
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96he expression seems to be age-dependent and may vary
rom very mild (isolated bifid uvula) to severe (multiple
neurysms, dissections, or death at a young age).10
AOS is estimated to be responsible for 2% of familial
horacic aortic aneurysms and dissections, as well as intra-
ranial, aortic and bilateral iliac aneurysms segregating in an
utosomal-dominant manner.8,12 The incidence of AOS in
atients with primary visceral and iliac artery aneurysms is
urrently unknown and remains to be determined.
The major source of early death in AOS is aortic root
ilatation, potentially leading to aortic dissection and rup-
ure.9 In some individuals, aortic dissection occurred at
elatively mildly enlarged aortic diameters.8-10 However,
rterial involvement is not limited to the aorta, but can be
idespread, with peripheral and intracranial aneurysms and
rterial tortuosity, thereby resembling Loeys-Dietz syn-
rome.9,13,14 Furthermore, early-onset osteoarthritis is
resent in nearly all patients and is useful to discriminate
OS from other connective tissue disorders.8-10 The osteo-
rthritis is often the first reason the individual seeks medical
dvice, with a mean age at diagnosis of 42 years (youngest,
2 years old).8-10 Although the genetic background and
horacic aortic pathology of SMAD3-related AOS have
een described before, so far the vascular consequences of
OS beyond the aortic root have not been highlighted.
herefore, the purpose of this study was to evaluate the
OS-related vascular abnormalities in the visceral and iliac
rteries and raise awareness for this aggressive syndrome
mong vascular specialists.
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The study was approved by the Institutional Review
Board and Ethical Committee of the Erasmus MC in
Rotterdam. Written informed consent was obtained from
each patient.
Patients. The medical records of the 45 identified
AOS patients10 were reviewed to evaluate visceral and iliac
vascular abnormalities. As previously described, aneurysmal
findings included thoracic aortic aneurysms (72%), abdom-
inal aortic aneurysms (12%), aneurysms in other thoracic or
abdominal arteries (36%), and intracranial aneurysms
(38%).9,10 Aortic dissection/rupture was present in 33% of
patients.9,10 AOS diagnosis was confirmed by genetic anal-
ysis and clinical phenotype.10 All AOS patients were inten-
sively monitored at regular intervals according to our clin-
ical AOS protocol.9 Only AOS patients with one or more
visceral or iliac aneurysms or tortuosity, or both, were
included in this report.
Data collection. Clinical data were collected from
chart abstraction and electronic patient records. Collected
variables included demographics, medical history, family
history, cardiovascular imaging, and (endo) vascular inter-
ventions. Computed tomography angiography (CTA) or
magnetic resonance angiography (MRA) from head-to-
pelvis was used to evaluate the presence of vascular abnor-
malities. An experienced cardiovascular radiologist evalu-
ated presence, location, and size of aneurysms, dissections,
and tortuosity. An aneurysm was defined as a dilatation of
an artery by 1.5 times the expected arterial diameter.
Visceral arterial tortuosity was defined as a severe (pigtail-
like) curve or multiple curves in an artery. Aortic and iliac
tortuosity was defined as described by Chaikof et al.15
RESULTS
The study included 17 AOS patients with visceral and
iliac aneurysms (n 15) or tortuosity (n 9), or both. The
primary reason for presentation in one patient was a symp-
tomatic visceral or iliac artery aneurysm. This 32-year-old
man presented with pain and a pulsating mass in the lower
abdomen, which was caused by bilateral aneurysms in the
common iliac arteries (69 and 42 mm; patient 1). In the
remaining 16 patients, the visceral or iliac artery aneurysms
were found when extensive imaging was performed at the
time of identification of AOS because of an aortic dissection
(n  5), aortic root aneurysm (n  6), or screening of
asymptomatic family members (n 5). Baseline character-
istics are summarized in the Table.
Overall, these 17 AOS patients exhibited 73 aneu-
rysms, of which 46 were located in the abdomen (Fig 1).
Detailed information about each individual patient is pro-
vided in the Supplementary Table (online only). Aneu-
rysms were most frequently found at the common iliac
artery (17 aneurysms in 10 patients), followed by the
superior mesenteric artery (seven aneurysms), celiac trunk
(five aneurysms), and splenic artery (four aneurysms). Ad-
ditional aneurysms were found in the external iliac, internal
iliac, hepatic, renal, gastric, gastroduodenal, and femoral trtery. The majority of patients (59%) also had an aortic
oot aneurysm. In six patients the abdominal aorta was
ilated (range, 23-100 mm), and four patients exhibited a
ype B aortic dissection. Chronic bilateral common iliac
rtery dissections were present in one patient at a diameter
f 9 and 17mm (none tomild dilatation). Extensive arterial
ortuosity was noted throughout the arterial tree, most
requently located in the vertebral, iliac, splenic, carotid,
nd intracranial arteries (Fig 2; Video 1, online only).
Aneurysm growth. Repeated CTA or MRA scans
ere available in six patients, and rapid growth of an
neurysm was noted in two patients. A 30-year-old man
patient 8) had a 6-mm fusiform aneurysm in the left
roximal vertebral artery, which increased to 11 mmwithin
0 months. An aneurysm in the right hepatic artery in a
3-year-old man (patient 7) increased in size from 11 to 18
m in 9 months’ time. Furthermore, a completely new
usiform aneurysm (15  11 mm) in the left gastric artery
normal diameter, 7 mm) developed in patient 7 within 11
onths’ time. The scans in the patients 3, 4, 11, and 15 did
ot show aneurysmal growth in a time period of 1 to 3
ears.
Elective vascular interventions. Four patients under-
ent six elective open or endovascular interventions for
neurysms in the iliac, hepatic, gastric, or splenic artery.
atient 1, a 32-year-old man with bilateral large iliac artery
neurysms, underwent aortobiiliac graft implantation
Gelsoft prosthesis; Vascutek, Renfrewshire, UK). No peri-
perative complications occurred. A follow-up MRA at 1
onth showed relative stenoses of the distal anastomoses
ue to progressive tortuosity and elongation of the native
ommon and external iliac arteries that were reimplanted
n the prosthetic limbs (Fig 3). At 3 months, he required a
esh repair of an incisional hernia, which was likely related
o the abnormal collagen composition due to AOS.
Patients 4 and 10 underwent coil embolization with
cclusion of the splenic artery both proximal and distal to
able. Baseline characteristics of patients with
neurysms-osteoarthritis syndrome
ariablea Mean  SD or No. (%)
atients 17
ge, years 47  13
ale sex 8 (47)
ody mass index, kg/m2 24  4
lood pressure, mm Hg
Systolic 131  17
Diastolic 95  8
holesterol, mmol/L
Total 5.0  1.1
High-density lipoprotein 1.5  0.4
Low-density lipoprotein 3.1  0.9
-blockade medication 3 (18)
moking
Never 15 (88)
Current 2 (12)
D, Standard deviation.he aneurysm (Fig 4; Video 2, online only). Both patients
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January 201398 van der Linde et alFig 1. Distribution of 73 aneurysms within 17 patients with aneurysms-osteoarthritis syndrome. PDA, Patent ductus
arteriosus.Fig 2. Arterial tortuosity in (A) aorta, visceral and iliac arteries, and (B) in the splenic artery.
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which was most likely due to splenic ischemia and ade-
quately managed with analgesics.
Patient 7, a 35-year-old man, underwent surgical resec-
tion with end-to-end anastomosis of a splenic artery aneu-
rysm. He presented 5 years later with abdominal pain. CTA
revealed an expanding hepatic artery aneurysm for which a
covered self-expandable stent graft (Viabahn; W. L. Gore,
Flagstaff, Ariz) was implanted in the extrahepatic part of
this aneurysm, thereby closing of a second small saccular
intrahepatic artery aneurysm (Supplementary Fig, online
only). This patient successfully underwent coil emboliza-
tion of a fusiform aneurysm in the left gastric artery 6
months later.
After a postprocedural period of 1month to 8 years, the
four patients who underwent elective interventions were
alive and asymptomatic.
DISCUSSION
To our knowledge, this is the first report describing the
implications of SMAD3-related AOS in the visceral and iliac
arteries. Although previous studies mainly focused on the
genetic background and thoracic aortic involvement8-10; it
is important to raise awareness for the vascular conse-
Fig 3. A, A three-dimensional magnetic resonance ang
(69 and 42mm).B,A postoperative cardiac magnetic reso
due to progressive tortuosity and elongation of the nativquences of AOS beyond the aortic root. aGeneral features of AOS. AOS is a recently described
utosomal-dominant disorder that can predispose patients
o widespread arterial aneurysms, dissections, and tortuos-
ty.8-10 Although AOS may resemble other connective
issue disorders such as Loeys-Dietz syndrome, it can be
iscriminated by the presence of early onset joint anomalies
uch as osteoarthritis, osteochondritis dissecans, and me-
iscal abnormalities.10
Mutations in the SMAD3 gene have been identified as the
nderlying cause for AOS.8 The most likely effect of these
utations is loss of function and a paradoxic increase in
ransforming growth factor- signalling in the aortic wall.10
n histology of aortic wall fragments, evident disorganization
f the tunica media with fragmentation and loss of elastic
bers was observed, as well as characteristic mucoid medial
egeneration and accumulation of collagen in media.8
AOS seems to be responsible for 2% of familial poly-
neurysm disease.8,12 Because AOS has only been identi-
ed recently, data regarding the natural history of the
isease are scarce, although it has become evident that
neurysmal growth can be fast and unpredictable and dis-
ections may occur in only mildly dilated arteries.9 In
ddition, AOS is also associated with additional features that
re common in connective-tissue disorders, such as umbilical
phy (MRA) shows bilateral large iliac artery aneurysms
e image shows relative stenoses of the distal anastomoses
arteries.iogra
nancnd inguinal hernias, pelvis floor prolapse, varices, scoliosis,
A
a
e
a
a
m
t
e
s
t
t
A
d
JOURNAL OF VASCULAR SURGERY
January 2013100 van der Linde et aland velvety skin.8-10 Furthermore, mild craniofacial features,
including hypertelorism (widely-spaced eyes) and uvula ab-
normalities (broad or bifid) might be present.8-10
Involvement of the visceral and iliac arteries in AOS.
The visceral and iliac arteries in our patient group dis-
played widespread abnormalities, such as aneurysms and
extreme tortuosity. Although aneurysms were encoun-
tered in many arteries, splenic and iliac artery aneurysms
were often the largest aneurysms and therefore most
frequently required treatment. Moreover, arterial tortu-
osity was also most prominent in the splenic and iliac
arteries. Although widespread arterial tortuosity and an-
eurysms can also be found in Loeys-Dietz and arterial
tortuosity syndrome, this is rare in patients with Marfan
syndrome.13-17 Therefore, this feature can be helpful to
Fig 4. A, A three-dimensional computed tomograph
aneurysm (21 mm) and tortuosity. Coil embolization p
proximal to the aneurysm.discriminate AOS patients from Marfan patients. pIt would be interesting to elucidate why the arteries of
OS patients become tortuous. Mechanical stability of
rteries highly depends on elastin, which provides arterial
lasticity and stiffness.18 Elastin degradation weakens the
rterial wall, thereby compromising mechanical stability of
rteries.18 Studies in fibulin-4– and fibulin-5–deficient
ice and humans have demonstrated the association be-
ween arterial tortuosity and profound failure of elastogen-
sis.19 Aortic wall specimens of AOS patients also demon-
trated elastin degradation.8 Therefore, we hypothesize
hat failure of elastogenesis is the probable cause of arterial
ortuosity in AOS patients.
Endovascular treatment in AOS patients. Because
OS can be complicated by dissections at relatively small
iameters, early elective aneurysm repair seems to be appro-
iography and (B) angiography show a splenic artery
ure to occlude of the splenic artery (C) distal and (D)y ang
rocedriate to avoid vascular catastrophes. Nevertheless, poten-
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intervention. Knowledge of aneurysmal growth, proce-
dural complication rates and late postoperative outcomes is
crucial. Although rate of aneurismal growth is not entirely
elucidated yet, it has become clear that growth can be fast
and unpredictable. The current general consensus in ath-
erosclerotic aneurysmal disease is that (endo) vascular treat-
ment is indicated in asymptomatic visceral artery aneurysms
2.0 cm and iliac artery aneurysms 3.0 cm.20-25 How-
ever, due to the sometimes rapid aneurysmal growth and
occurrence of dissections in only mildly dilated arteries, a
more aggressive treatment strategy seems to be necessary in
AOS patients.
So far, (endo) vascular treatment experience in AOS
patients is limited due to the recent discovery of this syn-
drome. Although this report only describes six (endo)
vascular interventions in four AOS patients, it represents
the largest cohort of abdominal (endo) vascular interven-
tions to date. In vascular-type Ehlers-Danlos syndrome,
friable vascular tissue leads to high surgical complication
rates.7 In contrast, fragility of arterial tissue was not an issue
in the described interventions in AOS patients nor in aortic
surgery.9 Tissue handling felt the same as in patients with-
out a connective tissue disorder; thus, elective interventions
seem to be feasible and safe in AOS patients so far.
Although endovascular treatment of aortic aneurysms
is generally discouraged in patients with connective disor-
ders, little is known about open vs endovascular repair of
visceral aneurysms in patients with connective-tissue disor-
ders.26 In our opinion, the potential harmful impact of
persistent radial forces of a stent graft is less of an issue in
the visceral arteries than in the aorta and no issue with coil
embolization. Furthermore, visceral aneurysms might be
difficult to reach and treat through an open surgical proce-
dure, and periprocedural morbidity and mortality will gen-
erally be lower in endovascular procedures. Therefore, we
usually prefer an endovascular approach in AOS patients,
although we strongly encourage an individualized ap-
proach weighing all potential benefits and harms, and mul-
tidisciplinary deliberation before deciding on the treatment
strategy.
Clinical implications. Vascular specialists should be
aware of AOS as a potential underlying cause of visceral and
iliac aneurysms or tortuosity, or both, especially in patients
with aortic aneurysms or dissections, joint complaints, mul-
tiple arterial aneurysms or a strong family history of aortic
dissections or sudden death. Patients should be offered
genetic testing and counseling for SMAD3 gene mutations
when AOS is suspected. In addition, at least a transthoracic
echocardiogram should be performed to look for an aortic
root aneurysm. If a mutation is identified, additional coun-
seling of family members is strongly recommended.
Because AOS is notable for unpredictable, sometimes
rapid aneurysmal growth and occurrence of dissections in
mildly dilated arteries, imaging of the entire arterial tree
with CTA or MRA should be performed annually in con-
firmed AOS patients.9 OTo prevent aneurysm rupture or dissection, or both,
lective (endo) vascular intervention in AOS patients
hould be considered in any visceral or iliac artery aneurysm
xceeding twice the expected arterial diameter and in those
hat grow rapidly (3 mm/y). Open and endovascular
pproaches can be used safely; however, endovascular pro-
edures may be complicated by extreme tortuosity and
hould thus be performed by an experienced endovascular
pecialist. Imaging diagnostics using three-dimensional
TA or MRA reconstructions may be useful in planning
reatment. After aneurysm repair, the entire arterial tree
hould be monitored because it remains at risk for aneu-
ysm development and dissections or ruptures.
Study limitations. The retrospective nature and small
ample size of this study are evident limitations. However,
his study serves its most important goal, namely to raise
wareness for this new, aggressive aneurysm syndrome.
hen AOS patients are not recognized, vascular complica-
ions that might have been prevented may occur. Larger
rospective follow-up studies are warranted to elucidate the
linical course of AOS and long-term surgical outcome.
ONCLUSIONS
AOS is a recently discovered connective tissue disorder
hat predisposes patients to arterial aneurysms, dissections
nd tortuosity, and early-onset joint complaints. Extensive
TA or MRA screening frequently identified (multiple)
neurysms and extreme tortuosity within visceral and iliac
rteries in these patients. Although surgical experience is
imited, fragility of arterial tissue does not seem to compli-
ate open and endovascular procedures in AOS patients.
wing to the occurrence of dissection in mildly dilated
rteries, a more aggressive treatment strategy seems to be
ecessary. To prevent rupture, elective aneurysm repair
hould be considered in any visceral or iliac artery aneurysm
hat exceeds twice the expected arterial diameter or grows
apidly. It is paramount that vascular specialists are aware of
his new syndrome and its aggressive behavior since many
OS patients are still unrecognized.
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